Global /China /Healthcare /Biotechnology /688197

Shouyao Holdings (Beijing) Co., LTD.

688197

• SSE: 688197 • Delayed

40.85CNY 0.6%

6.04 USD

As of 16 June 2026, Shouyao Holdings (Beijing) Co., LTD. has a market cap of $891.69M USD, ranking #11387 globally and #3288 in China. It ranks #1030 in the Healthcare sector, and #193 in the Biotechnology industry.

Global Rank

11387

Country Rank

3288

Sector Rank

1030

Industry Rank

193

Key Stats

Market Cap

$891.69MUSD

6.04B CNY

Enterprise Value

$797.83MUSD

5.4B CNY

Revenue (TTM)

$5.12MUSD

34.67M CNY

EBITDA (TTM)

-$24.69MUSD

-167.11M CNY

Net Income (TTM)

-$13.76MUSD

-93.17M CNY

Profit Margin

-269%

PS Ratio

174.2

PB Ratio

9.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Wenjun Li open_in_new

Employees

172

Founded

2016

Website

shouyaoholding.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.6%	5.2%	4.6%	13%	1.2%	17%	34%	-31%	0.4%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688197 首药控股(北京)股份有限公司 Class A ISIN: CNE1000062V6 Shares Out.: Shares Outstanding: 55.796M¹ Shares Float: 31.077M² TV: TradingView: SSE: 688197 SA: Stock Analysis: SHA: 688197 YF: Yahoo Finance: 688197.SS GF: Google Finance: SHA: 688197 BA: Barron's: 688197 MS: Morningstar: XSHG: 688197	40.85 CNY	TV: TradingView: SSE: 688197 SA: Stock Analysis: SHA: 688197 YF: Yahoo Finance: 688197.SS GF: Google Finance: SHA: 688197 BA: Barron's: 688197 MS: Morningstar: XSHG: 688197

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shouyao Holdings (Beijing) Co., LTD.

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.45B 136.71B HKD 2K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 1K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.01B 54.23B CNY 798%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.34B 49.69B CNY 723%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 694%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.72B 45.52B CNY 654%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 20K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 18K%	19.0	United States
argenx SE EBR: ARGX	$47.89B 41.39B EUR 5K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$45.02B 68.19T KRW 5K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.64B 60.27B AUD 5K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.17B 33.71B CHF 5K%	37.2	Switzerland

chevron_leftBack